Cargando…

Targeted Therapies in Epithelial Ovarian Cancer

Molecularly targeted therapy is relatively new to ovarian cancer despite the unquestionable success with these agents in other solid tumours such as breast and colorectal cancer. Advanced ovarian cancer is chemosensitive and patients can survive several years on treatment. However chemotherapy dimin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dean, Emma, El-Helw, Loaie, Hasan, Jurjees
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Molecular Diversity Preservation International 2010
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3827593/ https://www.ncbi.nlm.nih.gov/pubmed/24281034 http://dx.doi.org/10.3390/cancers2010088

Ejemplares similares

Small-Cell Lung Cancer: 8 Years Experience of a Single Multidisciplinary Team
por: El-Helw, Loaie M., et al.
Publicado: (2008)

Targeted Therapies in Epithelial Ovarian Cancer
por: Barrena Medel, Nicanor I., et al.
Publicado: (2010)

Epithelial Ovarian Cancer: Focus on Targeted Therapy
por: Markman, M., et al.
Publicado: (2010)

Targeted agents in epithelial ovarian cancer: review on emerging therapies and future developments
por: Lokadasan, Rajitha, et al.
Publicado: (2016)

Folate Transport and One-Carbon Metabolism in Targeted Therapies of Epithelial Ovarian Cancer
por: Wallace-Povirk, Adrianne, et al.
Publicado: (2021)

Targeting Signaling Pathways in Epithelial Ovarian Cancer
por: Smolle, Elisabeth, et al.
Publicado: (2013)

Antivascular Therapy for Epithelial Ovarian Cancer
por: Duhoux, Francois P., et al.
Publicado: (2010)

Histone deacetylases as new therapy targets for platinum-resistant epithelial ovarian cancer
por: Pchejetski, Dmitri, et al.
Publicado: (2015)

Genetic and epigenetic heterogeneity of epithelial ovarian cancer and the clinical implications for molecular targeted therapy
por: Bai, Huimin, et al.
Publicado: (2016)

Screening tool for malignant bowel obstruction in relapsed, metastatic ovarian cancer
por: Morgan, Robert D, et al.
Publicado: (2019)

Clinical utility of targeted treatments in the management of epithelial ovarian cancer
por: Twu, Cheryl, et al.
Publicado: (2012)

Histone Deacetylase Inhibitor Therapy in Epithelial Ovarian Cancer
por: Takai, Noriyuki, et al.
Publicado: (2010)

Is Reflex Germline BRCA1/2 Testing Necessary in Women Diagnosed with Non-Mucinous High-Grade Epithelial Ovarian Cancer Aged 80 Years or Older?
por: Morgan, Robert D., et al.
Publicado: (2023)

Targeted Therapy in Ovarian Cancer
por: Willmott, Lyndsay J., et al.
Publicado: (2010)

Ovarian Cancer: Biomarkers and Targeted Therapy
por: Radu, Mihaela Raluca, et al.
Publicado: (2021)

Harnessing Wnt signaling as a targetable therapy in epithelial ovarian cancer
por: Wall, Jaclyn A., et al.
Publicado: (2020)

Targeted therapy and immunotherapy: Diamonds in the rough in the treatment of epithelial ovarian cancer
por: Huang, Xu, et al.
Publicado: (2023)

Circular RNAs in Epithelial Ovarian Cancer: From Biomarkers to Therapeutic Targets
por: Qiu, Yumin, et al.
Publicado: (2022)

Targeting epithelial-mesenchymal transition and cancer stem cells for chemoresistant ovarian cancer
por: Deng, Junli, et al.
Publicado: (2016)

The Role of Epithelial-to-Mesenchymal Plasticity in Ovarian Cancer Progression and Therapy Resistance
por: Loret, Nele, et al.
Publicado: (2019)

Current Treatments and New Possible Complementary Therapies for Epithelial Ovarian Cancer
por: Garrido, Maritza P., et al.
Publicado: (2021)

Maintenance therapy for newly diagnosed epithelial ovarian cancer– a review
por: Nag, Shona, et al.
Publicado: (2022)

Psychosexual Morbidity in Women With Ovarian Cancer: Evaluation by Germline BRCA Gene Mutational Status
por: Logue, Chloe A., et al.
Publicado: (2021)

Ovarian Cancer: Opportunity for Targeted Therapy
por: Tagawa, Tomoko, et al.
Publicado: (2012)

BRCA1 as a Therapeutic Target in Sporadic Epithelial Ovarian Cancer
por: Clark-Knowles, Katherine V., et al.
Publicado: (2010)

New perspectives on targeted therapy in ovarian cancer
por: Coward, Jermaine IG, et al.
Publicado: (2015)

Ovarian cancer stem cells and targeted therapy
por: Keyvani, Vahideh, et al.
Publicado: (2019)

Local estrogen metabolism in epithelial ovarian cancer suggests novel targets for therapy
por: Ren, Xia, et al.
Publicado: (2015)

Olaparib in Epithelial Ovarian Cancer
por: Anastasia, Paula J.
Publicado: (2016)

Therapeutic strategies in epithelial ovarian cancer
por: Kim, Ayako, et al.
Publicado: (2012)

Treatment of recurrent epithelial ovarian cancer
por: Pisano, Carmela, et al.
Publicado: (2009)

Estrogen, Progesterone and Epithelial Ovarian Cancer
por: Ho, Shuk-Mei
Publicado: (2003)

Chemokine Receptors in Epithelial Ovarian Cancer
por: Muralidhar, Goda G., et al.
Publicado: (2013)

Immunotherapy Advances for Epithelial Ovarian Cancer
por: Hartnett, Erin G., et al.
Publicado: (2020)

The BRCA Gene in Epithelial Ovarian Cancer
por: Sánchez-Lorenzo, Luisa, et al.
Publicado: (2022)

Palliative systemic therapy for women with recurrent epithelial ovarian cancer: current options
por: Elit, Laurie, et al.
Publicado: (2013)

Epigenetic Therapies as a Promising Strategy for Overcoming Chemoresistance in Epithelial Ovarian Cancer
por: Suh, Dong Hoon, et al.
Publicado: (2013)

Epigenetic therapy for the treatment of epithelial ovarian cancer: A clinical review
por: Smith, Haller J., et al.
Publicado: (2017)

Antiangiogenic Strategies in Epithelial Ovarian Cancer: Mechanism, Resistance, and Combination Therapy
por: Jin, Chengwen, et al.
Publicado: (2022)

Maintenance therapy for recurrent epithelial ovarian cancer: current therapies and future perspectives – a review
por: Gupta, Sudeep, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_d7n9lgjnqdkt2e1bbs758kc7ta